PLK4 Is a Potential Biomarker for Abnormal Tumor Proliferation, Immune Infiltration, and Prognosis in ccRCC.
Chenglu HuQingping LiuChengyi HuYing WangPan WangXing ZhouPublished in: Computational and mathematical methods in medicine (2022)
The PLK4 expression is associated with the prognosis of ccRCC patients and affects the immune microenvironment of ccRCC, and PLK4 is expected to be a new target for the diagnosis and treatment of ccRCC.